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Abstract.  The mouse intestinal epithelium is able to 
establish and maintain complex lineage-specific, spa- 
tial, and temporal patterns of gene expression despite 
its rapid and continuous renewal. A multipotent stem 
cell located near the base of each intestinal crypt gives 
rise to progeny which undergo amplification and allo- 
cation to either enterocytic, Paneth cell, goblet cell, or 
enteroendocrine cell lineages. Differentiation of these 
four lineages occurs during their geographically or- 
dered migration along the crypt-villus axis.  Gut stem 
cells appear to have a "positional address" which is 
manifested by differences in the differentiation pro- 
grams of their lineal descendants along the duodenal- 
colonic (cephalocaudal) axis. We have used the intesti- 
nal fatty acid binding protein gene (Fabpi) as a model 
to identify cis-acting elements which regulate cell- and 
region-specific patterns of gene expression in the gut. 
Nucleotides -1178 to  +28 of rat Fabpi direct a pat- 
tern of expression of a reporter (human growth hor- 
mone [hGH]) which mimics that of mouse Fabpi (a) 
steady-state levels of hGH mRNA are highest in the 
distal jejunum of adult transgenic mice and fall pro- 
gressively toward both the duodenum and the mid- 
colon; and (b) hGH is confined to the enterocytic lin- 
eage and first appears as postmitotic, differentiating 
cells exit the crypt and migrate to the base of small 
intestinal villi or their colonic homologs, the surface 
epithelial cuffs. Nucleotides -103  to  +28,  which are 
highly conserved in rat, mouse and human Fabpi, are 
able to correctly initiate transgene expression in late 
fetal life, restrict hGH to the enterocytic lineage, and 
establish an appropriate cephalocaudal gradient of 
reporter expression. This cephalocaudal gradient is 
also influenced by cis-acting elements located be- 
tween nucleotides -1178 and  -278,  and  -277 and 
-185 that enhance and suppress (respectively) expres- 
sion in the ileum and colon and by element(s) lo- 
cated upstream of nucleotide -277  that are needed to 
sustain high levels of hGH production after weaning. 
Nucleotides -277 to  -185  contain part of a domain 
conserved between the three orthologous Fabpi genes 
(nucleotides -240 to  -159),  a 24-bp element (nucleo- 
tides  -212 to  -188) that binds nuclear factors present 
in colonic but not small intestinal epithelial cells, 
and a portion of a CCAAT/enhancer binding protein 
footprint (C/EBPa, nucleotides -188 to  -167). 
Removal of nucleotides  -277 to  -185  (yielding 
i_FABP-lS4 to +2S/hGH+3) results in inappropriate expres- 
sion of hGH in proliferating and nonproliferating epi- 
thelial cells located in the mid and upper portions of 
duodenal, jejunal, ileal, and colonic crypts without 
affecting the "shape" of the cephalocaudal gradient of 
transgene expression. Despite this precocious induc- 
tion of hGH production, the hGH reporter remains re- 
stricted to the enterocytic lineage in both the small in- 
testine and colon suggesting that these replicating 
crypt epithelial cells may already be allocated to this 
lineage at the point of induction of transgene expres- 
sion. Alternatively, these replicating, hGH-positive 
cells may not be fully committed to the enterocytic 
lineage but nucleotides -184 to  +28 contain cis- 
acting elements that bind factors which mediate 
lineage-specific expression. Together,  these results in- 
dicate Fabpi will be a useful model system for de- 
scribing the molecular mechanisms that maintain axial 
pattern formation in the perpetually renewed, lineal 
descendants of the multipotent crypt stem cell. 
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rIE adult mouse small intestine contains ,~1.1 million 
flask-shaped crypts of Lieberkiihn (Hagemann et al., 
1970), each composed of an average of 530 cells (du- 
odenum) to 360 cells (ileum) (Wright and Irwin, 1982). Cell 
division  in  the  intestinal  epithelium  is  confined  to  these 
crypts.  Studies  of normal,  chimeric,  and transgenic  mice 
suggest that each crypt is monoclonal,  containing  a single 
active multipotent stem cell and its descendants (Cheng and 
LeBlond,  1974e;  Ponder et al.,  1985;  Inoue et al.,  1988; 
Winton et ai,,  1988, 1989; Potten and Loeffler, 1990; Win- 
ton and Ponder,  1990;  Schmidt et al.,  1985a,  1990; Cohn 
et al., 1991; Roth et al.,  1991b). These descendants undergo 
amplification through several rounds of cell division (,- two 
thirds of the crypt's epithelial cell population pass through 
the cell cycle every 12 h) (Potten and Loeffler, 1987,  1990) 
and are allocated to four principal lineages.  Differentiation 
occurs during a geographically  ordered bipolar migration. 
Absorptive columnar enterocytes, mucus-producing goblet 
cells, and enteroendocrine ceils differentiate as they migrate 
in vertical coherent bands from the crypt to the apex of a sur- 
rounding villus where they are exfoliated. Paneth cells differ- 
entiate during their descent to the base of the crypt (Cheng 
and LeBlond,  1974a-d;  Potten and Allen,  1977; Partridge 
and Simpson,  1980;  Schmidt et al.,  1985b; Bjerknes and 
Cheng,  1981a,b). Proliferation, lineage allocation (commit- 
ment),  differentiation/migration,  and  exfoliation  are  pro- 
cesses which occur perpetually and are completed rapidly in 
the small intestinal epithelium (e.g., it takes 2-3 d for an en- 
terocyte to move from the upper crypt to the apical extrusion 
zone of a villus). A similar statement can be made about the 
colonic epithelium. A single active multipotent stem cell lo- 
cated at or near the base of each colonic crypt gives rise to 
each of the four epithelial cell lineages (Griffiths et al., 1988; 
Cohn et ai., 1991; Roth et al.,  1992b). The proliferative ca- 
pacity of colonic crypts is comparable with that of small in- 
testine crypts (Sunter et al.,  1979).  However, there are no 
villi in the colon. Cells migrate from colonic crypts to a hex- 
agonal-shaped cuff of surface epithelial cells that surround 
the orifice of each crypt (gland)  (Schmidt et al.,  1985b). 
Crypts form during the first two weeks of postnatal life. 
They arise from a polyclonal intervillus epithelium (i.e., one 
that has several active stem ceils) through a complex process 
that involves: (a) progressive deepening (invagination);  (b) 
a cell selection that results in "purification"  of the nascent 
crypt from polyclonality to monoclonality; and (c) division 
(crypt fission)  (Obuoforibo and Martin,  1977;  A1-Nafussi 
and Wright,  1982;  Cheng and Bjerknes,  1987; Schmidt et 
al.,  1988). Studies of mouse aggregation chimeras indicate 
that each small intestinal villus in the adult mouse is supplied 
by several  crypts,  i.e.,  it  is "polyclonal" (Schmidt  et al., 
1985b). The number of anatomically defined crypts that sur- 
round each villus varies as a function of location along the 
cephalocaudal  (duodenal-ileal)  axis:  the crypt-villus ratio 
decreases from 14 in the duodenum to 6 in the ileum (Wright 
and Irwin,  1982). Moreover, a given crypt can supply cells 
to several adjacent villi. It is unclear whether one or more 
adjacent colonic crypts supply cells to a given surface epi- 
thelial cuff. 
Since the intestinal  epithelium  undergoes perpetual  and 
rapid renewal of its four terminally differentiated cell types 
along  an  anatomically  well  defined  pathway  (i.e.,  the 
crypt-villus or crypt-surface epithelial cuff axis), and since 
each crypt is composed of the progeny of a single active mul- 
tipotent stem cell, the gut is an attractive system for: (a) in- 
ferring the biological properties of stem cells; (b) examining 
how stem cell hierarchies  are established and maintained; 
(c) analyzing the relationships between passage through the 
cell  cycle and  lineage  allocation  (commitment);  and  (d) 
defining differentiation programs (Gordon et al., 1992). The 
mouse intestine is, in essence, a continuous developmental 
system. An intriguing  additional  feature is its capacity for 
morphoregulation  (Edelman,  1992),  i.e.,  to establish  and 
maintain  distinct  regional  differences  in  gene  expression 
within specific cell lineages and in the relative proportions 
of the four lineages along the duodenal-colonic axis. Studies 
of jejunal, ileal, and colonic isografts, harvested just before 
conversion of the gut epithelium to a monolayer overlying 
nascent villi on embryonic days 15-16 and implanted into the 
subcutaneous tissues of young adult CBY/B6 nude mouse 
recipients, indicate that this regional differentiation of the gut 
epithelium can occur in the absence of luminal contents and 
suggest  that  a  crypt  stem  cell  has  a  "positional  address" 
describing its location along the cephalocaudal axis (Rubin 
et al., 1991,  1992). Although axial pattern formation reflects 
position-dependent  differences  in  the  differentiation  pro- 
grams of crypt stem cell descendants, the molecular mecha- 
nisms that produce polarity in the gut epithelium remain un- 
known. The cellular basis is also unclear. For example, how 
much positional information is encoded in stem cells them- 
selves? Do mesenchymal components, such as the pericryp- 
tal  fibroblasts  that  proliferate  and  migrate  along  the 
crypt-villus axis, help specify the crypt stem cell's positional 
address and/or influence the differentiation programs of its 
progeny (Marsh and Trier,  1974a,b; Maskens et al.,  1979; 
Haffen et al.,  1983,  1987; Kedinger et al.,  1986)? 
Transcription  of the mouse intestinal  fatty acid binding 
protein gene (Fabpi) ~ located on chromosome 3  (Sweetser 
et al., 1987; Green et al., 1992) is confined to the gut epithe- 
lium: its mRNA and protein products first appear as differen- 
tiaring  enterocytes exit small intestinal  and colonic crypts. 
Expression is sustained during subsequent migration to the 
apical extrusion zone of villi and to the surface epithelial cuff 
of colonic glands (Sweetser et al.,  1988a). Distinct regional 
differences in the steady-state concentrations of these gene 
products  also occur along the cephalocaudal  axis:  highest 
levels  are  present  in  the  distal jejunum  with  progressive 
decreases occurring toward either the proximal duodenum or 
the mid-colon (Sweetser et al.,  1988a).  These cell-specific 
and region-specific patterns of Fabpi are evident at the time 
of its initial activation in late fetal life (E16-coinciding with 
the first appearance of the gut epithelial monolayer), and are 
maintained  throughout adulthood (Sweetser et al.,  1988a; 
Green  et al.,  1992).  Analyses of intestinal  isografts have 
shown that the differentiation-dependent induction of intesti- 
nal  fatty acid binding  protein  (I-FABP)  synthesis and  the 
cephalocaudal variations in enterocytic I-FABP levels do not 
depend upon luminal signals (Rubin et al.,  1991,  1992). 
We have exploited these features of Fabpi to define cis- 
acting elements that regulate enterocyte-specific and region- 
specific patterns of gene expression in the mouse gut epithe- 
lium.  Preliminary  studies in transgenic mice indicated that 
1.  Abbreviations  used in  this paper:  Fabpi,  intestinal fatty  acid binding 
protein  gene;  IGSS,  immunogold/silver stained;  hGH,  human growth 
hormone. 
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Figure 1.  Summary of conserved elements present in the 5' nontranscribed domains of human,  rat, and mouse Fabpi. (A) Comparison 
of the orthologous Fabpi genes. Conserved domains I, II, and IlI are shown as stippled boxes and are described in Green et al., 1992. 
The positions of sequences homologous to a  14-bp element (consensus 5'-TGAACTTTGAACTT-3') found in Fabpi, other members of 
its gene family which are expressed in the gut, and in several nonbomologous genes that are also transcribed in the intestine (Sweetser 
et al., 1987)  are indicated by thick, black, vertical lines. The clark hatching shows a 82 repetitive element (Krayev et al., 1982) present 
in rat, but not human or mouse, Fabpi. (B) Summary of sequence elements present in I-FABP/hGH transgenes. 
nucleotides  -1178  to  +28  of rat Fabpi (Sweetser et al., 
1987) are sufficient to produce a pattern of reporter expres- 
sion in enterocytes distributed along the crypt-villus and 
duodenal-colonic axes which mimics that of the intact en- 
dogenous mouse and ratFabpi  genes (Sweetser et al., 1988a; 
Haufi et al., 1992).  Removal of nucleotides -1178 to -278 
restricted transgene expression to the proximal small intes- 
tine in the one pedigree that was available but did not affect 
expression along the crypt-villus axis, suggesting that dis- 
tinct cis-acting regulatory elements may modulate gene ex- 
pression  along the two axes of the gut (Sweetser  et al., 
198ga). Recent comparison of the nucleotide sequences of 
mouse, rat and human Fabpi  revealed  three  highly conserved 
domains in their 5' nontranscribed regions as well as multiple 
copies  of a  14-bp  element.  This  element  (consensus  5'- 
TGAACTTTGAACTT-39  is  a  direct repeat of a  7-bp  se- 
quence and is present in comparable positions of the 5' non- 
transcribed domains of  the orthologous Fabpi  genes (see Fig. 
1 A). It is also represented in the 5' nontranscribed domains 
of several other genes that are expressed in enterocytes in- 
cluding another member of the Fabpi gene family (Crbp2 
which encodes cellular retinol binding protein II) (Sweetser 
et al., 1987; Detainer et al., 1987). We have used this infor- 
mation and transgenic mice to conduct a more detailed func- 
tional analysis of the 5' nontranscribed region of Fabpi to 
understand  how  its  differentiation-dependent and  region- 
specific patterns of expression are regulated in the entero- 
cytic lineage. 
Materials and Methods 
Generation and Characterization of Transgenic Mice 
Construction of I-FABP/hGH Fusion Genes.  The I-FABP/human growth 
hormone (hGH) DNAs used to produce transgenic animals are illustrated in 
Fig. 1 B. I-FABP  -1178 to +28/hGH+3,  representing nucleotides -1178 to +28 
of  rat Fabpi (Sweetser et al., 1987) linked to the human growth hormone gene 
beginning at its nucleotide +3 (Seeburg,  1982),  is described in Sweetser 
et al. (1988a).  I-FABP  -zn  to +2s/hGi.i+3 was obtained by digesthlg pIFhGH1 
(Sweetser et al.,  1988a)  with EcoRI yielding a  2.4-kb EcoRI fragment. 
I.FABP-IU To +2$/hGH+3 and I-FABP  -103 to +2S/hGH+3 were retrieved from 
pIFhGH1 as 2.3-kb BstEII-EcoRI and 1.9-kb Sphl fragments, respectively. 
I.FABp-277 to -104/hGH-~ was produced as follows. A SacI-PvuII restric- 
tion fragment containing nucleotides -277 to  +28 of rat Fabpi was sub- 
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resulting recombinant  plasmid DNA was digested with SphI and BamHI and 
a double-stranded oligonucleotide  (5'-CAATGTAGCACAGAAACAGGTG- 
GGGTCAACAGTGGGAGAGAAGCCAGGGTATAAAAA~CCAC 
AAGAGACCAGCTCAAG375'GATCCTTGAGCTGGTCTCTTGTGC~ 
CCCTTTTTATACCCTGGCCCCTTCTCTCCCACTGTTGACCCCACC 
TGTFI'CTG~ACATI'GCATG-3~ representing nucleotides -84 to +3 
of the hGH gene (Seeborg, 1982) was inserted in place of the SphI-BamHI 
fragment that contained nucleotides -103 to +28 of rat Fabpi. Finally, a 
3.7-kb BamHI fragment from pIFhGH1 (i.e., a fragment which contains the 
hGH structure gene beginning at its nucleotide +3) was subcloned into the 
BamI-II site of the recombinant plasmid. I-FABP -277 to -104/hGH-S4 was re- 
covered  as a 2.4-kB EcoRI fragment and used for pronuclear injections. 
ProducgonandldentiflcationofTrartsgenicMtce.  All restriction frag- 
ments used for pronuclear injections were purified by agarose  gel elec- 
trophoresis followed by the GeneClean system (Biol01, Inc., La Jolla, CA). 
DNA fragments were injected into the pronuclei of oocytes obtained from 
mating C57BL/6J X C3H F1 mice. Oocytes were transferred on the day of 
injection to the infundibulum  of the fallopian  tubes of pseudopregnant Swiss 
Webster mice (Hogan et al.,  1986).  Live born mice were subsequently 
screened for the presence of the transgene by probing Southern blots of 
EcoRI digested tall DNA  with a  32p-labeled (Feinberg and Vogelstein, 
1984)  2.2-kb BamHI-EcoRI fragment of pIFhGH1  containing the hGH 
gene beginning at its nucleotide  +3. Founder mice were mated to C57BL/6J 
X C3H F1 animals to establish pedigrees  that were obligate  bemizygotes 
for  the  transgene.  Lines  were  subsequently  maintained by  littermate 
breeding. 
Calculation of Copy Number.  To determine transgene copy  number, 
genomic DNA was prepared from the liver or spleen of F1 mice.  15/~g of 
DNA were digested with PvuII, an enzyme that cleaves the hGH gene at 
two sites yielding a 1-kb internal fragment from each copy of an I-FABP/ 
hGH transgene. The products of EcoRI digestion were separated by agarose 
gel electrophoresis and transferred to nylon membranes (GeneScreen Plus, 
Dupont, New England Nuclear,  Boston, MA). Southern blots were probed 
with  the  32p-labeled  2.2-kb  BamHI-EcoRI  fragment of pIFhGH1  de- 
scribed above,  using hybridization and washing  stringencies detailed in 
Sweetser et al. (1988b). The intensity of the hybridization signal generated 
by the 1-kb band was quantitated by scanning laser densitometry of the filter 
autoradiograph and compared to the intensities of signals produced  by 
known amounts of cloned hGH DNA (added to 15 #g of liver or spleen 
DNA prepared from normal littermates and included in the same Southern 
blots as internal controls). Only signals in the linear range of film sensitivity 
were used to calculate  transgene copy number. 
Caging. Suckling,  weaning,  and adult mice were maintained in micro- 
isolator cages under a strictly controlled light cycle (lights on at 0600 and 
off at 1800 h). Weaning and weaned mice were given a standard autoclava- 
ble chow diet ad libitum. For pregnant mice, gestational age was calculated 
from the day a vaginal plug was first noted (designated  day 1). 
Preparation of 7issue RNA.  Transgenic  mice and their normal litter- 
mates were sacrificed by cervical dislocation and their tissues rapidly re- 
moved. 90 rain before sacrifice,  some animals received an intraperitoneal 
injection of 5-bromo-2'-deoxyuridine  (BrdUrd; Sigma Chemical Co., St. 
Louis, MO) (dose ffi 30 mg/kg)  to label cells in S-phase  (Chwalinski  et 
al.,  1988) and 5-fluoro-2'-deoxyuridine  (Sigma Chemical Co.) (dose =  1 
mg/kg)  to inhibit endogenous thymidylate synthetase activity (Brinkman 
and  Dormier,  1972).  The  gastrointestinal tract  was  divided  along  its 
cephalocaudal axis as described by Sweetser et al., (1988b) yielding sag- 
ments that are described in the text as stomach (ST), duodenum (DU), prox- 
imal and distal jejunum (PJ and D J), ileum (IL), cecum (CE), proximal co- 
lon (PC) and distal colon (DC). A 0.2-0.5-cm section was obtained from 
the proximal, mid, and distal portions of each segment for subsequent im- 
munocytochemical studies (see below).  The rest of the tissue was quickly 
frozen in liquid nitrogen. Other tissues obtained at the time of sacrifice in- 
cluded brain, heart, lung, spleen, liver, kidney, pancreas, gonads, and skele- 
tal muscle. Total cellular RNA was extracted from frozen, pulverized tissue 
using guanidinium isothiocyanate,  phenol, and chloroform (Chomczynski 
and Sacchi, 1987). The integrity of RNA samples was assessed by formal- 
dehyde agarose gel electrophoresis. 
RNA Blot Hybridization Studies.  Samples of total cellular RNA were 
fractionated by denaturing, formaldehyde-agarose  gel electrophoresis and 
transferred to nylon membranes. RNA dot blots were used to quantitate 
steady-state levels  of specific  mRNAs  as  described in  Sweetser  et al. 
(1988a,b).  Blots contained in vitro transcribed, purified mouse I-FABP 
mRNA and hGH mRNA standards (0.1-500 pg, Sweetser et al.,  1988a,b; 
Green et al.,  1992) and were probed with either a 32p-labeled (Feinberg 
and Vogelstein,  1984) mouse I-FABP cDNA (Green et al., 1992) or a 150- 
bp BglII-PvulI fragment obtained from exert V of the hGH gene. Hybrid- 
ization and washing  conditions are detailed in our earlier publications 
(Sweetser  et al.,  1988a,b). The intensity  of the hybridization signal pro- 
duced by a given sample  of tissue RNA was determined by counting the 
filters with a Betascope Model 603 scanner (Betagen, Waltham,  MA) and 
compared with the signals obtained with the mRNA standards present in 
the same filter. This comparison allowed us to calculate the steady-state lev- 
els of specific mRNAs.  Note that the distribution of hGH mRNA along the 
duodenal-colonic axis of the gut was compared and contrasted with the dis- 
tribution of I-FABP mRNA by sequentially  probing dot and/or Northern 
blots of R.N/ks prepared from a given mouse.  Labeled DNA was removed 
after the first  round of hybridization/washing  by incubating  the blot at 
100~  in 1.5 mM NaC1/0.15 mM Na Citrate, pH 7.0/0.01% SDS.  The 
stripped blot was then reprobed with the second 32p-DNA. This direct com- 
perison allowed us to conclude whether the distribution of reporter (hGH) 
mRNA was qualitatively and/or quantitatively  similar to that of the Fabpi 
transcript and eliminated potential problems of interpretation  due to animal- 
to-animal variation in (a) precise sites of division of the intestinal tract into 
duodenal, proximal and distal  jejunal, ileal, cecal and colonic segments and 
(b) the relative  steady-state  levels of I-FABP mRNA in these segments. 
lmmunocytochemical Studies.  Tissue samples were fixed in Bonin's so- 
lution (Sweetser et al., 1988/7). Material obtained from the seven segments 
of intestine from a given animal were placed on a single slide together with 
samples of stomach, liver, pancreas,  and kidney. All tissues were then em- 
bedded in paraffin and 5-10 #m sections  were prepared.  This allowed us 
to simultaneously  survey cellular patterns of gene expression in several or- 
gans and to compare and contrast the steady state level of a specific protein 
as a function of cellular position along the two axes of the gut. The methods 
used for single- and double-label immunocytochemical studies  are de- 
scribed in previous publications (Roth et al., 1990; Hermiston et al., 1992). 
Briefly, paraffin was removed from sections which were then overlaid with 
a prinutry antiserum (diluted as described below) and placed in a humidified 
chamber, maintained at 4~  for 12-14 h. The primary antiserum was then 
removed  and the sections washed several times in PBS.  For single label 
studies, antigen-antibody complexes were detected with either fluorescent- 
labeled secondary antibodies (Jackson Immunoresearch Laboratories, West 
Grove, PA) or with gold-labeled secondary antibodies followed by silver en- 
hancement (Amersham Corp., Arlington Heights,  IL). For double and tri- 
ple labeling, immunogold/silver stained (IGSS) sections were washed with 
water and PBS followed by addition of a second and/or third primary antise- 
rum raised in a rabbit  or a goat. Silver deposition during the IGSS procedure 
effectively abolishes the antigenicity  of the first primary antiserum gold- 
labeled secondary antiserum complex, allowing detection of additional pri- 
mary antisera with fluorescent-labeled  secondary antibodies (Roth et al., 
1990; Hermiston et al., 1992). The second and third primary antisera were 
detected with fluorescein-labeled  donkey anti-goat and Texas red-labeled 
donkey anti-rabbit sera (Path et al.,  1990). The final dilutions of antisera 
used and their sources are as follows: goat anti-BrdUrd (1:2000) (Cohn and 
Lieberman, 1984); rabbit anti-rat I-FABP (Lowe et al., 1987); rabbit anti- 
hGH  (1:2,000)  (Dako  Corp.,  Santa Barbara,  CA),  and goat anti-hGH 
(1:2,000) (McKeel and Askin, 1978). The immunostalning characteristics 
and specificities of these antisera have been described in our earlier publica- 
tions (Sweetser  et al.,  1988a,b; Path et al.,  1990;  Green et al.,  1992). 
Measurement of hGH Levels in Serum by Radioimmunoassay.  Serum 
was collected from transgenic mice at various ages. Serum from each ani- 
mal was assayed in duplicate for hGH using a sensitive radioimmunoassay 
(Nichols Institute, San Juan Capistrano,  CA) whose limits of detection is 
0.5 ng/mi of hGH. It does not recognize mouse growth hormone as assessed 
by  surveys  of  sera  obtained  from  nontransgenic littermates  (data  not 
shown). 
Preparation of Nuclear Extracts from Intestinal 
Epithelial Cells 
A modification of the procedure of Gorski et al. (1986) was used to isolate 
nuclear proteins from small intestinal and colonic epithelial cell popula- 
tions. The intestine was removed en bloc (i.e., from the gastroduodenal 
junction to the rectum) from 2-3-me-old mice and then divided at the il- 
eal/cecal border. A 22-gauge, blunt-end needle, attached to a 30-ml syringe, 
was inserted into the duodenum and the lumen of the small intestine per- 
fused with an ice cold solution of TBS buffer (10 raM Tris, pH 7.6, 150 mM 
NaC1). The small bowel was then placed in ice cold homogenization buffer 
(10 mM Hopes,  pH 7.6, 25 mM KCI, 1 mM EDTA,  1 mM DTT, 2 M su- 
crose, 2 mM benzamidine, 0.2 mM phenylmethylsulfonylfluoride,  0.5 mM 
spermidine,  0.15 mM spermine,  10% glycerol [vol/voi]). The mucosa was 
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intestine with the blunt end of a spatula. The remaining fibromuscular tissue 
was discarded. After removal of luminal contents, the colon was minced in 
ice cold homogenization buffer rather  than scraped.  The scraped mucosa 
from each small intestine or the minced colonic tissue was brought to a total 
volume of 8 ml with homogenization buffer (maimained at 4~  2aypicaily, 
material  obtained  from the small intestine  or colon of three animals was 
pooled and adjusted to a final volume of 28 nil. N-acetyl-L-cysteine (Sigma 
Chemical Co.) and Triton X-100 were then added to final concentrations 
of 50 mM and 0.5%,  respectively. The mixture was homogenized with a 
Tissumizer (Teknmr Co., Cincinnati,  OH) set at maximum speed 0-5 30- 
sec bursts were applied with the tube containing the homogenate placed on 
ice).  Aliquots  of the  resulting  28-ml  suspension  were examined  using 
phase-contrast  microscopy to assure that the majority of  cells had been dis- 
rupted.  The 28-ml  suspension  was  subse4uently  layered over 10 ml of 
homogenization buffer and nuclei pelletaxt by centrifugation at 80,000 gave 
for 50 rain at 4~  The resulting pellet was resuspended in 2 ml of ice cold 
nuclear  extraction buffer (10 mM Hepes, pH 7.6, 0.l mM EDTA, 3 mM 
MgCI2,  t00 mM  KCl,  2  mM benzamidine,  0.2  mM phenylmethylsul- 
fonytfluoride,  1 nLM DTT, 10% glycerol) using a loose fitting pestle and 
Dounce  homogenizer.  NaOH was then added (final concentration  =  10 
mM) to an aliquot of  nuclei, and the absorbance of  the resulting lysate deter- 
mined at 260 nm.  This information  was used to adjust the volume of the 
remaining nuclear suspension to 10-20 A260/ml using ice cold nuclear ex- 
traction buffer. One-tenth volume of 4 M (NH4)2SO4, pH 8.0, was slowly 
added to the nuclear suspension and the mixture gently rocked for 30 rain 
at 4~  Chromatin was pelleted from the lysate by centrifugation at 100,000 
gave for 60 rain at 4~  The supernatant  fraction  was collected and 0.34 g 
of (NH4)2SO4 added  per milliliter.  After an overnight incubation on ice, 
precipitated material was recovered by centrifugation at I00,000 ga,~ for 25 
rain. The pellet was resuspended in an ice cold buffer composed of  25 mM 
Hepes, pH 7.6, 40 mM KCI, 0.1 mM EDTA, 1 mM DTT, 2 mM benzami- 
dine, 0.2 mM phenylmethylsulfonylfluoride, and 10% glycerol and dialyzed 
against the same buffer at 4~  (three changes of 100 eel of dialysis buffer, 
2-3 h per exchange). The concentration of  protein in the nuclear extract was 
determined using the method of Bradford (1976). Atiquots were then frozen 
in liquid nitrogen. Nuclear extracts were also prepared  from liver, kidney, 
and spleen using a protocol  identical to that described  above for colon. 
Mobility Shift Studies 
DNA binding assays were performed  in 25-t~1 reactions. The mixture con- 
tained 50 fmoles of template DNA labeled at one of its 5' ends with [32p] 
using  T4 polynucleotide  kinase  (New  England  Biolabs,  Beverly,  MA), 
0.5-1.0 #g of poly dt<lC (Pharmacia  Fine Chemicals,  Piscataway, NJ), 
varying amounts of one of the double-stranded  oligodeoxynuclcotide com- 
petitors described in the legend to Fig. 3, 25 mM Iris, pH 8.0, 50 mM KC1, 
0.I mM EDTA, and 5 mM 2-mercaptoethanol.  The solution was incubated 
at room tem4~eraturr for 30 rain and the products analyzed by electraphore- 
sis through 5 or 8% polyacrylamide gefs (running buffer =  25 mM Tris, 
190 mM glycine, 1 mM EDTA, final pH -- 8.5). After electrophoresis, gels 
were dried and subjected to autoradiography at -80~  using Kodak XAR-5 
film (Eastman Kodak Co., Rochester, NY) and an intensifying screen. 
DNAse I Footprint  Analysis Using Recombinant 
C/EBP~ and Fabpi 
E. coil-derived C/EBPtx vats a kind gift of Steve McKnight (Cat~gie Insti- 
tution of Washington, Baltimore,  MD) and was prepared as described  in 
Landschulz et al. (1988). The template DNA used for these studias was pre- 
pared by digesting plFhGHI with EcoRI. The resulting 2.4 kb EcoRI frag- 
ment  was purified  by agarose gel electrophoresis  and labeled  with [32p] 
using 1"4 polynucleotide  kinase.  Digestion with BamHI yielded a 312-bp 
EcoRI-BamHI fragment containing nucleotides  -277 to +28 of rat FabpL 
This  DNA was  purified  by  agamse  get  electrophoresis.  Alternatively, 
pIFhGH1 was digested with BamHI, the 3.7-kb fragment labeled with [a2p] 
at its 5' ends, and then incubated  with EcoRI yielding  a 312-bp EcoRI- 
BamHI fragment that was labeled at nucleotide  +28 of Fabpi rather than 
at nucleotide  -27Z  ,~3,000 cpm of either one of these [32p]DNAs was 
added to a reaction mixture (45 ~I) containing C/EBPu (final concentration 
=  30 ng/~l), 1 gg unlabeled poly dI-dC,  50 mM KCt, 25 mM Tris-HCl, 
pH 7.9, 6 mM MgCl2, 0.5 mM EDTA, and 10% glycerol. After a 10-rain 
incubation on ice and a 2-rain incubation at 23~  5/~1 of DNAase I (pre- 
pared in 25 mM CaCl2) was introduced into the mixture  at varying final 
concentrations which were determined empirically as a function of  both the 
DNAse I activity and the specific activity of the labeled DNA fragment. Af- 
ter a l-rain incubation at 23 ~C, DNAse I digestion was terminated by adding 
t10/~1 stop buffer (1% SDS, 200 mM NaC1, 20 mM EDTA, and 200 #g/ml 
proteinase K), placing the mixture at 55~  for 30 rain, and then extracting 
it with phenol and chloroform. The labeled DNA products were recovered 
by ethanol precipitation,  dissolved in loading dye (0.1% bromophenol blue, 
0.1% xylene cyanol, 80% formamide,  50 mM Tris-borate,  pH 8.3, and  1 
mM EDrA), and fractionated by electrophoresis  through a 7% polyacryt- 
amide gel containing  8 M urea. 
Results 
Comparative Sequence  Analyses of Orthologous Fabpi 
Genes and DNA Binding  Assays Using Nuclear 
Extracts Prepared  from Small Intestinal and Colonic 
Epithelial Cells Provide  a Design Rationale  for 
Conducting Functional  Mapping Studies 
As noted in the introduction,  earlier  studies in transgenic 
mice indicated  that nucleofides  -1178 to  +28 of rat Fabpi 
contain sufficient information to direct cellular and regional 
patterns  of  expression  of  at  least  two  reporters,  hGH 
(Sweetser et al.,  1988a) and SV-40 T antigen (Hauft et al., 
Figure 2.  Gel retardation  studies using nuclear extracts prepared 
from the mouse proximal small intestinal epithelium or colon and 
nucleotides  -241  to  -188  of rat Fabpi.  Nuclear extracts  were 
prepared from duodenal and jejunal mueosal scrapings and from 
the colon as described  in Materials and Methods,  A  a2p-labeled 
double-stranded  oligonucleotide  template  spin'ruing  nucleotides 
-241 to -188 of  rat Fabpi was incubated with the indicated amount 
of  protein from each of these nuclear extracts and the products ana- 
lyzed by electrophoresis through nondenaturing 8% polyacrylamide 
gels. An atltoradiograph Of  the gel is shown. Note that extracts from 
these different regions of the cephalocaudal axis of the gut produce 
different patterns  of retarded bands. 
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tor(s) to nucleotides  -212 to -188 of rat Fabpi. (A) Nuclear ex- 
tracts  from colon (3 #g total protein)  were incubated with 0.05 
pmole of a 32P-labeled 54-bp fragment spanning nucleotides  -241 
to  -188 plus the  indicated amount of unlabeled  oligonucleotide 
competitors.  The reaction products  were  fractionated  by nonde- 
naturing PAGE. Note that all competitors which contain the nucleo- 
tide  sequence  5'-TGCTGTAGTCGGAGACAGAGTAGGT-3'  (nu- 
cleotides  -212 to  -188) compete for binding of colonic nuclear 
factors to bands a and b. Competition  for binding to band c was 
only observed with the same oligonucleotide that was used as the 
labeled template (-241 to -188, data not shown) and, to a lesser 
extent,  by the oligonucleotide  which  spans nucleotides  -212 to 
-158. NE, no extract added;  "-" no oligonucleotide competitor 
added. (B) Summary of the results presented in A, demonstrating 
the relationships of the various oligonucleotide competitors to the 
conserved  sequence elements present  in Fabpi and to a C/EBP~ 
binding site identified by DNAse I footprint analysis (see Fig. 4). 
The sequences of the unlabeled double-stranded  oligonucleotides  used as competitors  are as follows: -277 to  -228; 5'-AATTCGA- 
GCTCGGATTAAAGGTGGAAGCCATCACACTTGACCCTAATTCTTCK3A-3'; -248 to  -220;  5'-CACTTGACCCTAATTCTTG- 
GAATAAAAAT-3'; -241 to -188; 5'-CCCTAATTCTTGGAATAAAAATGCCTACATGCTGTAGTCGGAGACAGAGTAGGT-3';-229 
to  -  188, 5'-GAATAAAAATGCCTACATGCTGTAGTCC~AGACAGAGTAGGT-3';-219  to  -188, 5'-GCCTACATGCTGTAGT- 
CGGAGACAGAGTAGGT-3';-212 to  -158; 5'-TGCTGTAGTCGGAGACAGAGTAGGTATGGTTACCAAATTTGAATGCAGTT- 
GAATC-3';  -157 to  -117,  5'-TCAGCAATAGATTCAAAGAAAGCACTAGAAGAGAAACTAAA-3'. 
1992), that mimic that of the intact endogenous Fabpi gene. 
The cellular and regional patterns of Fabpi expression are 
quite similar in humans, rats, and mice (Shields et al., 1986; 
Sweetser et al.,  1988a; Green et al.,  1992).  Therefore, we 
reasoned  that  the  three  conserved  sequence  elements  lo- 
cated in the 5' nontranscribed domains oftbe orthologous hu- 
man, rat, and mouse Fabpi genes (labeled I-IR in Fig.  I A) 
and  sites in  their  5' nontranscribed  domains  that  specifi- 
cally bind intestinal  nuclear proteins are likely to contain 
cis-acting regulatory sequences  important for establishing 
and maintaining cell-specific and/or region-specific patterns 
of expression. 
Nuclear proteins were prepared from the duodenal/jejunal 
epithelium and from the colon of adult mice (see Materi- 
als and Methods). Gel mobility shift studies were then per- 
formed using these extracts, or control extracts from liver, 
kidney,  and  spleen,  and  DNA  fragments  derived  from 
nucleotides -277 to +28 of rat Fabpi (i.e., those nucloatides 
sufficient to support reporter expression in villus-associated 
enterocytes located in the proximal half of the small intestine 
of transgenic  mice). Nuclear  extracts  from the  proximal 
small intestine and the colon produced distinct patterns of 
shifted bands when a  32p-labeled  DNA fragment spanning 
nucleotides  -241 to  -188 was used as a template (Fig. 2). 
Markedly different patterns were noted with liver, kidney, 
and spleen extracts (data not shown). Moreover, incubation 
of proximal small intestinal or colonic nuclear extracts with 
other,  double-stranded oligodeoxynucleotide templates de- 
rived from nucleotides -277 to +28 yielded a set of shifted 
bands that included subsets which migrated in a similar fash- 
ion to those shown in Fig. 2  and subsets that were distinct 
(data not shown). Analysis of these results revealed that two 
prominent shifted bands were only present when colonic ex- 
tracts were incubated with nucleotides  -241  to  -188  0a- 
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to the reaction mixture containing this template DNA and 
colonic nuclear extracts resulted in a single band that had the 
same mobility as the free a2p-labeled  54-bp oligodeoxynu- 
cleotide, indicating that the shifted bands were likely due to 
the binding of proteins present in the colonic nuclear extract 
(data not shown). 
The region(s) in the -241 to -188 fragment that reacted 
with colonic nuclear proteins to produce bands a and b was 
further defined in  a  series of competitive binding  studies 
using  unlabeled  double  stranded  oligodeoxynucleotides 
(Fig. 3, A and B). All oligonucleotides that contained a 24- 
base sequence representing nucleotides -212 to -188 of rat 
Fabpi (5'-TGCTGTAGTCGGAGACAGAGTAGGT-3') were 
efficient competitors as judged by their ability to reduce the 
amount of labeled bands a  and b but not band c (Fig. 3 A). 
Other oligonucleotides that did not contain this 24-bp ele- 
ment (e.g., -248 to -220 or -157 to -117) were ineffective 
competitors even when present in >100-fold molar excess 
relative to the -241 to -188 template (Fig. 3, A and B). Fi- 
nally, each of the oligonucleotides used in the competition 
experiments was  labeled with 32p, incubated  with colonic 
nuclear extracts, and the reaction products subjected to na- 
tive gel electrophoresis. Their patterns of reactivity with co- 
Ionic nuclear proteins (as judged by gel shifts) mirrored their 
ability to reduce the amount of labeled bands a  and b (data 
not shown).  Together, these data  suggest that nucleotides 
-212 to -188 contain a binding site(s) for one or more pro- 
teins represented in colonic, but not proximal small intesti- 
nal, nuclear extracts. 
Members  of  the  CCAAT/enhancer  binding  protein 
(C/EBP) family of transcription factors (Cao et al.,  1991; 
Williams  et ai.,  1991;  Ron and  Habner,  1992) have been 
shown to affect the transcriptional activities of several genes 
during cellular differentiation (Umek et al., 1991), including 
a member of the Fabpi gene family known as aP2 (Hunt et 
al.,  1986) which is induced during adipocyte differentiation 
(Herrera et al., 1989; Christy et al., 1989; 1991; Cao et al., 
1991).  These  observations,  together  with  recent  studies 
which indicate that C/EBPot and related leucine zipper pro- 
teins are produced in the mouse intestine (Birkenmeier et al., 
1989;  Cao  et  al.,  1991),  caused  us  to  examine  whether 
nucleotides  -277 to  +28 contained any binding sites that 
reacted with E.  coli-derived  C/EBPct (Landschulz et al., 
1988). DNAse I footprinting revealed a single protected site 
that spanned nucleotides -188 to -167 of rat Fabpi (Fig. 4). 
This footprint lies within one of the three conserved Fabpi 
domains shown in Fig.  1 A (domain II) and is immediately 
adjacent to the colonic nuclear factor binding site. No other 
nuclear proteins were present in the recombinant C/EBPa 
preparation used for these studies thereby precluding the for- 
marion of heterodimers with other C/EBP isoforms (Wil- 
liams  et al.,  1991)  or with other trans-acting factors that 
might, in turn, alter its binding site specificity (Lamb and 
McKnight,  1991).  Unfortunately, we  have been unable to 
obtain unambiguous footprints in this region of Fabpi using 
either colonic or small intestinal nuclear extracts. This fail- 
ure may be due to a number of  causes including, for example, 
(a) partial degradation of C/EBPoe  and other transcription 
factors by intracellular and/or luminal (pancreatic) proteases 
during preparation of our nuclear extracts and (b) C/EBPa's 
extraordinarily  low  concentration  in  the  gut  epithelium. 
Figure 4.  DNAse I  footprint 
analysis reveals a binding site 
for recombinant C/EBP~x lo- 
cated  between  nucleotides 
-188 and -167 of rat Fabpi. 
E.  coli-derived rat  C/EBPc~ 
was  incubated with  a  32p-la- 
beled, 312-bp fragment of rat 
Fabpi  spanning nucleotides 
-277 to  +28.  DNAse I was 
subsequently added to the re- 
action mixture and the diges- 
tion  products  were  analyzed 
by electrophoresis through a 
7%  polyacrylamide gel con- 
taining  8  M  urea.  Parallel 
lanes  contained the products 
of sequencing reactions (Maxam and Gilbert,  1977) performed on 
the same labeled DNA fragment. The sequence of Fabpi that was 
protected from DNAse I digestion by C/EBPot is shown. 
Only  the  most  sensitive  immunocytochemical techniques 
such  as  the  immunogold/silver  intensification  staining 
method combined with reflected light polarization micros- 
copy are able to detect C/EBPot in jejunal villus-associated 
enterocytes. Moreover, enterocytic levels decrease markedly 
in the distal small intestine and the protein is undetectable 
in the colonic epithelium (C.  Chandrasekaran, K. A. Roth, 
and J.  I.  Gordon, unpublished observations). 
The results presented above provided us with a rationale 
for constructing  several recombinant DNAs  composed of 
elements  from the  5' nontranscribed domain of rat Fabpi 
linked to the human growth hormone (hGH) gene beginning 
at its nucleoride +3 (hGH was selected because it had been 
used as a reporter in the earlier functional studies of Fabpi). 
I-FABP  -277 to +2S/hGH+3 contains conserved domains H and 
HI,  a  single copy of the  14-bp repeat (see Fig.  1 B),  the 
binding sites for the protein factor(s) present in colonic nu- 
clear extracts,  and  C/EBPot.  I-FABP  -~u  to +2S/hGH+3 con- 
tains the proximal half of conserved domain II and all of 
conserved domain HI but lacks the colonic nuclear factor 
binding site and the 5' four bases of the C/EBPc~ footprint. 
I-FABP  -~~  to §  contains conserved domain III with 
its associated  14-bp element, TATA and CCAAT boxes. A 
final  construct,  I-FABP  -277  to  -~04/hGH-U  '  contains  con- 
served domain II plus the colonic factor and C/EBPot bind- 
ing  sites linked to hGH beginning at its nucleotide  -84. 
(Other investigators have linked putative tissue specific en- 
hancer elements to hGH, beginning at its nucleotide -84, 
to test their functional properties; e.g. Hammer et al., 1987; 
Ornitz et al.,  1987.) A number of transgenic pedigrees were 
established containing each of these fusion genes (Table I). 
Nucleotides -1178 to -278 Modulate Expression of 
Fabpi in the Distal Half of the Small Intestine and in 
the Colon 
The highest steady-state level of I-FABP mRNA in 20-wk- 
old nontransgenic mice is encountered in the distal jejunum 
and ileum (60-70 pg//~g total cellular RNA). Its concentra- 
tion in duodenum and colon ranges from 10-15%  of that 
achieved in the distal jejunum (Fig. 5 A). Transgenic mice 
containing 200-600  copies of I-FABP  -t~Ts to +2S/hGH+3 ex- 
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Number of  Number of  Designation of  Transgene copy 
liveborn mice  founders  pedigrees that  number/ 
Transgene  screened  identified  expressed transgene  haploid  genome 
I_FABP-Ii7s ,o +2S/hGH+3  40  2  1  **  600 
4"*  200 
I_FABP-277 ,o +2S/hGH+3  200  11  54*  60 
8*  2-4 
18  8 
I.FABP-lS4  ~o +2S/hGH+3  117  20  2w  4 
12  1-2 
36*  1 
39  1-2 
50  20 
55  2 
89  1 
I_FABP--277  to -iO4/hGH-84  111  10  none  ND 
I_FABP-i03  to +2S/hGH+3  190  8  35w  8 
40  2 
46w  4 
* Sterile  founder. 
* See Sweetser et al.  (1988a). 
w Poor fertility  in these transgenic animals limited the number of mice that were available for detailed  analysis. 
< 
z  250 
-~ 200 
o 
o  150 
O~ 
::L 
~  100 
< 
Z  r  50 
E 
m  0 
A 
ST  DU  PJ  CE  PC  DC  DJ  IL 
z  350  n,- 
_~ 300 
o  e  250 
200 
O~ 
150 
O) 
D. 
100  <: 
Z 
r  50 
E 
""  0 
B 
ST  DU  PJ  DJ  IL  CE  PC  DC 
Figure 5. Comparison of the distribution of  I-FABP and hGH mRNAs 
along  the  gastric-colonic  axis  of 21-wk-old  I-FABP  -uTs to +2s/ 
hGH  +3 mice ([]) and their normal littermates  (n) representing  two 
different pedigrees.  Total cellular RNA was prepared from stomach 
(ST),  duodenum (DU), proximal jejunum  (PJ), distal jejunum 
(D  J), ileum (ILL cecum (CE), proximal colon (PC), and distal co- 
lon (DC). Steady-state levels of I-FABP and hGH mRNA were de- 
termined by quantitative  RNA dot blot hybridizations.  Two trans- 
hibit a  pattern  of hGH mRNA distribution  along the duo- 
denal-colonic axis that is similar to that of I-FABP mRNA 
although their levels of I-FABP mRNA are up to three times 
higher than in normal littermates (Fig. 5, A and B). The in- 
creased steady-state concentration of I-FABP mRNA could 
reflect  the effect of transgene  copy number:  the  200-600 
copies of I-FABP  -n78 to +2VhGH+Vhaploid genome may bind 
nuclear transcription factors and thereby affect their ability 
to interact with the intact endogenous Fabpi gene. 
Removal of nucleotides  -1178 to  -278 (containing con- 
served domain I and its associated 14-bp element plus a 14- 
bp element 5' to domain I) (Fig.  1 A), produces a  marked 
reduction in reporter expression in the distal small intestine 
and no detectable hGH mRNA in the colon. This was ob- 
served in multiple  members of two pedigrees of mice that 
were analyzed at several stages of postnatal development (2, 
3, 12, and 18-21 weeks of age, Fig. 6) and in a sterile 32-wk- 
old founder mouse ((3o8, data not shown). The presence of 
2-60 copies of the I-FABP  -277 ~ +2S/hGH+3 transgene had no 
qualitative  or  quantitative  effect  on  the  regional  patterns 
of expression of Fabpi along the cephalocaudal axis of the 
gut as judged by RNA blot hybridization  studies  of these 
animals and their normal littermates (data not shown). Sur- 
veys of stomach, brain, lung, liver, pancreas, kidney, spleen, 
muscle,  and  gonadal  RNAs  prepared  from mice in  three 
I_FABp-277 to +2S/hGH+3 pedigrees  failed to detect any hGH 
mRNA (limits of detection  =  0.2 pg hGH mRNA//zg total 
cellular RNA). These data confirm that cis-acting elements 
genic mice from I-FABP  -n78 to +2S/hGH+3 lines  1 (zx) and 4  (A) 
(Sweetser et al., 1988a) were analyzed together with normal litter- 
mates (o,o). The bars represent the average of the data obtained 
from individual animals. The asterisks indicate that no hGH mRNA 
was detected (limits of sensitivity of  the RNA blot hybridization as- 
say  =  0.2 pg hGH mRNA//~g total cellular RNA). 
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Figure 6.  Distribution of hGH mRNA along the gastric-colonic 
axis of 2-21-wk-old I-FABP  -277 to +WhGH+3 transgenic mice from 
two different pedigrees.  Total cellular RNA was prepared from in- 
testinal  segments  harvested  from members of I-FABP  -277 to +28/ 
hGH  +3 lines  18 and 54 (see Table I). The concentration of hGH 
mRNA  in  these  preparations  was  determined  as  described  in 
Materials  and Methods.  N.D, not determined because the yield of 
RNA from the duodenum of these 2-wk-old transgenic mice was 
not sufficient to allow accurate quantitation  of hGH mRNA levels. 
(*) Not detectable. 
located between nucleotides  -1178 to  -278 support trans- 
gene expression in the distal intestine and colon and contrib- 
ute to establishment of a proper cephalocaudal distribution 
of reporter mRNA. 
Nucleotides -277 to -  184 Contain cis-acting 
Elements That Suppress Transgene Expression in 
Distal Small Intestinal and Colonic Enterocytes 
and in Their Crypt Epithelial Cell Populations 
Removal of nucleotides  -277 to -185 (containing a portion 
of conserved domain II, the colonic nuclear factor binding 
site,  and  four  nucleotides  of the  C/EBPot  footprint)  "re- 
stored" reporter expression in the distal small intestine and 
colon. Of the 20 founder mice containing I-FABP  -~s4 to +28/ 
hGH  §  that were identified,  obligate hemizygous mice from 
60 
40 
20 
0  N.D.~ 
ST DU  PJ 
O 
2 WKS 
[] Go55 
[] Go2 
<  0 
z 
rr 
DJ  IL  CE  PC  DC 
30 I 
-5  3-4 WKS 
20  ~  "  o 
s 
:~  0  --e  ST DU  PJ  DJ  IL  CE PC DC  I 
12 WKS 
<  20  z  o.- 
E  10 
=  N 
..c:  ST DU  PJ  DJ  IL  CE PC DC 
2030  I  ~  18-21 WKS 
ST  DU  PJ  DJ  IL  CE  PC  DC 
Figure 7.  Distribution  of bGH mRNA along the gastric-colonic 
axis of 2-21-wk-old I-FABP  -Is4 to +2S/hGH+3 transgenlc mice.  RNA 
was prepared from members of I-FABP  -~u to +2S/hGH+a transgenlc 
mice belonging to lines 2 and 55 (see Table I). Measurements  of 
hGH mRNA levels during postnatal weeks 2-4 were only made on 
mice derived from Go55 (n  =  2-3 littermates  for each of these 
time points,  each animal is represented  by either a closed circle, 
an open circle circle or an open triangle). N.D., not determined (see 
legend to Fig.  6). 
six established lines that contained hGH-positive sera were 
characterized.  Fig.  7  shows that the concentration of hGH 
mRNA in ileal and colonic segments harvested from 2-21- 
wk-old  members  of two  representative  I-FABP  -lu  ,o  +W 
hGH  §  pedigrees ranged from 20-80% of jejunal levels. In- 
appropriate  expression  of the  transgene  occurred  in  the 
stomach but in none of the other 8 tissues examined. (Immu- 
nocytochemical surveys of  portions of the zymogenic, muco- 
parietal and pure mucous zones of the stomach (defined ac- 
cording to Lee et al.,  1982 and Roth et al.,  1992a), failed to 
reveal  hGH-positive  cells.  Our  inability  to  find  reporter- 
positive cells despite the presence of hGH mRNA in stomach 
RNA could either be due to a sampling error or the fact that 
the steady-state levels of hGH in gastric epithelial  cell lin- 
eages (Karam and Leblond,  1992) were below the limits of 
detection by the IGSS technique.) The relative and absolute 
concentrations  of I-FABP mRNA along the cephalocaudal 
axis were similar in I-FABp-277to+2S/hGH+3, I-FABP  -1~ ,o +28/ 
hGH  +a transgenics and in their comparably aged normal lit- 
termates  (data not shown). 
Cohn et al. Axial Pattern Formation in the Gut Epithelium  35 Figure 8. Multilabel immunocytochemical studies of the distribution of I-FABP and hGH along the crypt-villus and crypt-surface epithelial 
cell cuff axes of adult I-FABP  -t~78 to +28/hGH+3, I_FABP-277 to +28/hGH+3, I_FABP-~84 to +28/hGH+3 transgenic mice and their normal litter- 
mates. (A-D) Fabpi is activated in enterocytes as they exit crypts and migrate to the base of small intestinal villi or their colonic homologues, 
the surface epithelial cuff. Sections from the small intestine (A-C) and proximal colon (D) from a nontransgenic mouse illustrate the normal 
cellular distribution of I-FABP. In A-C the section was incubated with goat anti-BrdUrd and rabbit anti-I-FABP sera.  Antigen-antibody 
The Journal of Cell Biology, Volume 119, 1992  36 Removal of nucleotides  -277 to -185 also affects cellular 
patterns of transgene  expression along the crypt-villus and 
crypt-surface epithelial cuff axis of the gut. Double-label im- 
munocytochemical  studies of normal and transgenic  mice, 
treated with 5-bromo-2'-deoxyuridine (BrdUrd) 90 min be- 
fore sacrifice to label cells in S phase, reveal that I-FABP is 
first detectable  in nonproliferating  enterocytes  as they exit 
small intestinal and colonic crypts and migrate onto the base 
of villi or the surface epithelial cuffs (Green et al.,  1992 and 
Fig. 8, A-D). (Comparative immunocytochemical and RNA 
blot hybrdizafion studies of transgenic mice and their nor- 
mal littermates treated with BrdUrd or vehicle alone indi- 
cated the nucleoside analog had no qualitative or quantita- 
tive effect on the cellular and regional patterns of Fabpi and 
I-FABP/hGH expression.) None of the proliferating, BrdUrd- 
positive cells located in the lower and middle thirds of these 
crypts contain I-FABP. Adult I-FABP  -277 to +28/hGH§  trans- 
genics only express hGH in nonproliferating, villus-associated 
enteroeytes located in the proximal two thirds  of the small 
intestine  (Fig.  8, G and H). In contrast to I-FABP  -~t78 ,o +2V 
hGH  +3 (Fig.  8, E  and F) and I-FABP  -27v ~~ +2VhGH  +3 trans- 
genic animals,  adult I-FABP  -~s" to §  mice produce 
hGH in villus enterocytes and in both proliferating and non- 
proliferating  epithelial  cells  located  in  the mid  and  upper 
thirds of the crypt (Fig.  8, I-L).  The hGH reporter is also 
present in enterocytes located in the upper portion of colonic 
crypts  and  in  the  surface  epithelial  cuff  (Fig.  8,  M-P). 
Despite its  inappropriate  production  in proliferating  crypt 
epithelial cells, hGH was not detectable in differentiating or 
differentiated members of the goblet, Paneth, or enteroendo- 
crine cell lineages. 
Nucleotides -  103 to + 28 of Fabpi Are SuJficient to 
Establish Enterocyte-specific and Region-appropriate 
Patterns of Transgene Expression along the 
Duodenal-Colonic Axis 
Nucleotides  -277 to -104 of Fabpi were linked to a neutral 
promoter/reporter (the hGH gene beginning at its nucleotide 
-84 [see above]) to test the possibility that this 174-bp frag- 
ment which contains conserved domain II, plus the colonic 
factor and C/EBPu binding sites but no copies of the 14-bp 
element (Fig.  1 B), can modulate expression along the crypt- 
villus and/or duodenal-colonic  axes.  Ten I-FABP  -277 ,o -~04/ 
hGH  -~ pedigrees  were established  (Table I).  No hGH ex- 
pression was detected in intestinal or extraintestinal  tissues 
harvested from one-wk-old and/or  adult animals  that were 
members of each of these lines. Thus,  it appears likely that 
sequences  contained  within  nucleotides  -277  to  -104  of 
Fabpi  are  not  sufficient  to  direct  intestinal  expression  of 
Fabpi.  However,  we  could  not exclude the possibility that 
these 174 bp could function as a tissue-specific element if it 
were linked to a  different heterologous  promoter/reporter. 
In contrast,  cis-acting  elements contained within  103 bp 
of  the  start  site  of  transcription  of Fabpi  appear  to  be 
sufficient to establish an appropriate cephalocaudal gradient 
of hGH expression and to confine this reporter to the entero- 
cytic lineage. This conclusion is based on the following ob- 
servations. We identified seven founder transgenic mice con- 
taining nucleotides  -103 to +28 linked to nucleotide  +3 of 
hGH. This sequence contains conserved domain III, an as- 
sociated 14-bp dement and the TATA and CCAAT boxes of 
Fabpi (Fig.  1 B). Three of these founders expressed hGH and 
complexes were then detected with fluorescein-labeled donkey anti-goat and Texas red-labeled donkey anti-rabbit sera, respectively. S 
phase cells labeled with BrdUrd are confined to the lower and middle thirds of crypts, labeled c in A. Diffuse enterocytic staining for 
I-FABP is seen in the villus epithelium, labeled v in B. Double exposure of BrdUrd and I-FABP immunostaining in C clearly illustrates 
the distinct geographic distributions of S phase cells and I-FABP immunoreactive enterocytes. In the proximal colon (D), I-FABP im- 
munoreactivity can be seen as a dark black precipitate using the IGSS detection method and is largely confined to the surface epithelial 
cuff. Immunoreactive cells in the surface epithelial cuff are indicated by a closed arrow while I-FABP-negative cells deep in the crypt are 
indicated by open arrows. (E and b') I-FABP  -uTs to +2S/hGH+3 directs a pattern of hGH accumulation in differentiating members of the en- 
terocytic lineage which mimics the pattern of accumulation of I-FABP. A section from the proximal small intestine of a 20-wk-old transgenic 
mouse stained for hGH by the IGSS method shows intense Golgi-associated staining of villus enterocytes (E). The crypt cell zone (labeled 
c) appears negative for hGH in this section which was lightly counterstained with hematoxylin. Visualization of this section with the sensi- 
five, reflected light polarization microscopy technique (F) fails to reveal any traces of hGH immunoreactivity in the crypt cell zone (c) 
while villus-associated enterocytes exhibit intense Golgi labeling. (G and H) hGH is restricted to villus-associated enterocytes in the prox- 
imal small intestine of I-FABP  -277 to +2S/hGH+3 transgenic mice. hGH immunoreactivity in G, detected by the IGSS method and visualized 
with reflected light polarization microscopy, is found in villus-associated enterocytes while cells in the crypt (c) are unlabeled. The crypt 
cell zone is clearly identified  in Hby the presence of BrdUrd-labeled cells (visualized with Texas red--labeled secondary antibodies). (I-L) 
I.FABP-~U to +28/hGH+3 is inappropriately expressed in small intestinal crypts. A section of proximal small intestine from a transgenic 
mouse was incubated with rabbit anti-I-FABP and goat anti-hGH sera. Antigen-antibody complexes were detected with Texas red-labeled-, 
and fluorescein-labeled donkey anti-rabbit and anti-goat secondary antibodies, respectively. (L) I-FABP immunoreactivity is restricted 
to villus-associated enteroeytes. The hGH reporter seen in J  extends into the crypt cell zone (arrows). This crypt cell expression can be 
further defined in animals treated with BrdUrd 90 min before sacrifice. A high power view shows immtmoreactive hGH in the Golgi appara- 
tus of crypt epithelial cells (K), some of which are in S phase as indicated by their BrdUrd-labeled nuclei (L; double exposure of hGH- 
labeled  cells  [IGSS,  reflected  light  polarization  microscopy]  and  BrdUrd-labeled  cells  [Texas  red]).  (M-P)  I-FABP  -l~  to  +28/ 
hGH  +3 is expressed in both crypt and surface epithelial cuff cell populations in the colon. (M) I-FABP immunoreactivity is present in 
the uppermost region of colonic crypts and in surface epithelial cuff cells. (N) scattered BrdUrd-labeled ceils are seen in the lower segments 
of the crypt. (O) hGH immunoreactivity is seen in both the surface epithelial cuff and in the mid-crypt region. The triple exposure in 
P shows extension of hGH immunoreactivity down to BrdUrd-labeled cells. (Note: the turnover rate of epithelial cells in the colon is longer 
than that in the small intestine,  resulting in fewer BrdUrd-labeled cells/crypt after a 90-min labeling period than observed in the small 
intestine.) Bar, 25 izm. 
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Figure 9. Distribution of hGH mRNA along the gastric-colonic  axis of 2-wk-old I-FABP  -~~  to §  transgenic mice from three 
different pedigrees. (A) A blot of total cellular RNA, prepared from portions of the cephalocaudai axis of the gut and 7 extraintestinal 
tissues of a Go35-derived mouse, was probed with a 32p-labeled, 150-bp fragment recovered from exon V of hGH. Each lane contains 
15 ~g of total cellular RNA. An autoradiograph of the RNA blot is shown. (B) Quantitation ofhGH mRNA levels along the cephalocaudai 
axis of the intestine of representative members of pedigrees 35, 40, and 46 (see Table 1-). (*) Not detectable. 
were used to establish pedigrees. F1 and/or F2 mice from 
two of these lines exhibited gastrointestinal-specific expres- 
sion of the reporter (e.g., see Fig. 9 A) while another (de- 
rived  from  Go46)  demonstrated  expression  in  stomach, 
small and  large intestine,  kidney, lung,  brain,  spleen and 
pancreas  (data  not  shown).  However,  all  three pedigrees 
demonstrated  a  duodenal-colonic  distribution  of  hGH 
mRNA (Fig. 9 B) which mimicked that of I-FABP mRNA 
in  the  same  preparation  of total  cellular RNA  (data  not 
shown). Peak levels of reporter mRNA were encountered in 
the distal jejunum of 2-wk-old suckling mice and ranged 
from 2-10 pg//~g total cellular RNA. Immunocytochemical 
studies demonstrated that removal of nucleotides  -184 to 
-104 had no effect on the restriction of hGH expression to 
the enterocytic lineage (see Fig.  11  K-N).  Moreover, the 
presence of 2-8 copies of the I-FABP  -'~  ~ +28/hGH  §  trans- 
gene had no qualitative or quantitative effect on the regional 
or cellular patterns of mouse Fabpi expression (see Fig.  11, 
L and N). 
Developmental Patterns of Fabpi/hGH Expression 
As noted in the introduction, Fabpi  not only represents a sen- 
sitive marker of enteroeytic differentiation along the crypt- 
villus and crypt-surface epithelial cuff axis, it is also a mo- 
lecular marker of the process of cytodifferentiation that the 
gut undergoes during late fetal life. This process is initiated 
in the proximal small intestine during E15-E16 and proceeds 
in a proximal-distal "wave" that travels along the cephalo- 
caudal axis during late gestation transforming the stratified 
intestinal endoderm to a monolayer of epithelial cells that 
overlie nascent villi. Transcriptional activation of Fabpi oc- 
curs in villus-associated enterocytes located in the proximal 
small intestine at the same time that morphologic transfor- 
mation of its endoderm is initiated (i.e., E15-16) (Green et 
al., 1992). Initiation of Fabpi expression follows the wave of 
cytodifferentiation  that proceeds rapidly along the duodenal- 
colonic axis (Rubin et al., 1989,  1992; Green et al.,  1992). 
We measured  serum hGH levels and  performed multi- 
label  immunocytochemical surveys  of late  gestation  and 
suckling  I-FABP  -277 ~  +28/hGH+3,  I-FABP  -t~ ~o +28/hGH+3  ' 
and  I-FABP  -~~  ~ +2S/hGH+3  transgenic  mice  to determine 
whether their transgenes exhibited appropriate developmen- 
tal stage-specific patterns of activation and whether the cel- 
lular patterns of reporter accumulation along the evolving 
duodenal-colonic and crypt-villus axis mimicked those of 
Fabpi. hGH first appears  in the serum of I-FABP  -277 ~ .28/ 
hGH  +3 and I-FABP  -lu'~ +2S/hGH  +3 mice at the time that Fabpi 
is activated in the proximal small intestine (Fig.  10, A and B). 
hGH is also present in the serum of I-FABP  -t~  ~~ +2S/hGH  +3 
mice on the day of birth, which was the earliest time point 
we surveyed (Fig.  10 C).  Serum hGH concentration peaks 
during the  suckling period (postnatal days  1-14)  and then 
declines during weaning (postnatal days 15-28) in mice con- 
taining each of these three I-FABP/hGH transgenes (Fig.  10 
A-C). The postnatal decreases in serum hGH levels docu- 
mented during the suckling/weaning period are accompanied 
by decreases in the steady-state levels of hGH mRNA along 
the cephalocaudal axis of the gut (compare the upper two 
panels  in Figs.  6  and 7  with Fig.  10,  A  and B).  I-FABP 
mRNA concentrations do not fall during the suckling/wean- 
ing period (e.g., see Green et al., 1992). However, a number 
of gene products show marked changes in their levels at the 
suckling/weaning transition in both the rat and mouse. Many 
of these alterations have been ascribed to increases in gluco- 
corticoid levels which  occur at this  stage of development 
(reviewed in Henning et al., 1987). Therefore, we wondered 
whether the glucocorticoid responsive element present in in- 
tron I of hGH (Moore et al.,  1985) mediated the observed 
declines in I-FABP/hGH expression. However, administra- 
tion of hydrocortisone acetate (25/~g/g body weight per day) 
to Gol 8-derived I-FABP  -277 ~o +2S/hGH.3 mice, from postnatal 
days 7-10, produced only minimal (<50%) reductions in se- 
rum hGH levels compared with transgenic littermates that 
had been treated with vehicle alone. 
Surveys  of 1-14-d-old  I-FABP -277t~ +2S/hGH+3, 
I_FABP-I~  to +2S/hGH  '  and I-FABP  -~~  =~ +2S/hGH+3 mice in- 
dicated that the presence of the transgene had no effect on 
the cellular patterns of I-FABP accumulation along the na- 
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Figure 10.  Serum hGH levels in E16-E20, suckling, and wean- 
ing I-FABP/hGH transgenic mice.  1-15 mice from the indicated 
pedigrees were examined at each of the ages shown, hGH concen- 
trations were determined in each serum sample in duplicate and the 
results were averaged. Data are expressed as the average serum 
hGH concentration among comparably aged mice from a given line 
+  SEM. The limits of detection of the assay are 0.5 ng/ml serum. 
(A) Data derived from members of I-FABP  -277 to +28/hGH+3 lines 
18 and 54; (B) values documented in members of I-FABP  -t~* ,o +28/ 
hGH  +3 pedigrees 12 and 55; (C) serum hGH levels in members of 
I_FABP-t03 to +2S/hGH+3  line 40. Further analysis of I-FABP  -zn to +28/ 
hGH  +3 and I-FABP  -l~ to +28/hGH+3  transgenic mice from the same 
pedigrees indicated that hGH levels remained constant from the 
35-250 days of life (data not shown). 
scent crypt-villus and duodenal-colonic axes (Fig.  11 and 
data not shown). Like I-FABP, hGH was confined to entero- 
cytes overlying nascent villi in I-FABP  -277 to +28/hGH+3 mice 
(Fig. 11, A-G). Removal of nucleotides -277 to -185 pro- 
duced inappropriate expression of hGH in the intervillus epi- 
thelium but still restricted this reporter to the enterocytic lin- 
eage in  small  intestinal  villi (Fig.  11,  H  and I).  Finally, 
distinct differences in the steady-state levels of hGH were 
evident  in  enterocytes  distributed  along  the  duodenal- 
colonic axis. These differences were noted at the time of ini- 
tial activation of each of the transgenes (e.g., Fig. 11, H and 
J). They were subsequently maintained during the suckling 
period and parallel cephalocaudal differences in the steady- 
state concentration of hGH mRNA (Figs.  6, 7, and 9). 
Discussion 
Fig.  12  describes the  functional elements that have been 
identified in the 5' nontranscribed domain of Fabpi from the 
studies described above. Analysis of  I-FABP/hGH transgenic 
mice  have  provided  insights  about:  (a)  the  mechanisms 
which permit cephalocaudal differences in gene expression 
to be sustained in a continuously renewing gut epithelial cell 
lineage; (b) how gene transcription is regulated in entero- 
cytes as they differentiate during their migration along the 
crypt-villus axis; (c) the relationship between proliferation 
and lineage allocation; and (d) the "temporal" gradient of 
gene expression that affects the gut epithelium. 
Our results suggest that the spatial patterns of Fabpi ex- 
pression observed along the duodenal-colonic and crypt- 
villus (or crypt-surface epithelial cuff) axes reflect the con- 
tributions of positive and negative cis-acting transcriptional 
regulatory elements which lie within 1 kb of its start site of 
transcription. Remarkably, nucleotides -103 to +28 of rat 
Fabpi are sufficient to direct lineage-appropriate expression 
and to establish a duodenal-colonic distribution of reporter 
mRNA accumulation in enterocTtes which mimics that of 
mouse I-FABP mRNA. These 132 bp include (a) a sequence 
which extends from nucleotide -94 to -1 that is conserved 
between three orthologous Fabpi genes and (b) a  14-bp ele- 
ment which is represented in at least one other family mem- 
ber (Crbp2) whose enterocyte-specific and geographic pat- 
terns of expression resemble those of Fabpi. However, the 
functional significance of these elements remains to be de- 
fined. A detailed search of a relational database of known 
transcriptional regulatory elements (Ghosh, 1990) failed to 
reveal  any members,  other than  TATA and  CCAAT  box 
elements, represented within nucleotides -103 to +28. The 
gradient of I-FABP mRNA levels observed along the cepha- 
locaudal axis appears to be modulated by two additional cis- 
acting spatial regulatory elements: a domain or domains lo- 
cated between nucleotides -1178 and -277 which promotes 
expression in the ileum and colon and a domain or domains 
located between nucleotides  -277 and  -184,  which oper- 
ates to suppress ileal and colonic expression (Fig. 12). This 
latter portion of the 5' nontranscribed domain of Fabpi in- 
cludes  a  24-bp  element,  spanning  nucleotides  -212  to 
-188, that binds nuclear factors present in colonic but not 
proximal small intestinal epithelial cells. The suppressor and 
colonic factor binding domains have no obvious sites recog- 
nized  by  known  transcription  factors  and  are  contained 
within a portion of Fabpi (nucleotides -277 to -104) that 
is not sufficient to support expression of the hGH reporter 
in any lineage in any portion of the gut epithelium. (The use 
of various combinations of a limited number of positive and 
negative elements could permit diverse regional patterns of 
expression of genes along the cephalocaudal axis of the gut. 
For example, it will be interesting to determine which of 
these elements in Fabpi, if any, are represented in a homolo- 
gous gene encoding ileal lipid binding protein [ILBP]. Ilbp 
expression is limited to ileal, villus-associated enterocytes in 
weaning and adult mice [Sacchettini et al., 1990; M. Cross- 
man, S. Hauft, K. Roth, and J. Gordon, unpublished obser- 
vations].) 
Cohn et al, Axial Pattern Formation in the Gut Epithelium  39 Figure 11. Comparison of cellular distribution  of I-FABP and hGH along the nascent crypt-villus axis of proximal small intestinal segments 
prepared  from suckling I-FABP  -277 to +2S/hGH+3, I.FABP-lS4  to +2S/hGH+3, i_FABP-t03  to +2S/hGH+3 transgenic mice and their normal litter- 
mates.  (A-G) transgene expression in developing  I-FABP  -277 to +2S/hGH+3 mice is limited to villus-associated  enterocytes.  A section of 
small intestine from a 1-d-old I-FABP  -277 ~o §  transgenic mouse was incubated with rabbit anti-I-FABP and goat anti-hGH sera 
and visualized with Texas red and fluorescein-conjugated  secondary  antibodies, respectively.  Diffuse cytoplasmic  I-FABP immunoreac- 
tivity (A) and intense Golgi staining  for hGH (B) are seen in villus-associated  enterocytes. The colocalization  of I-FABP and hGH immuno- 
reactivity and the lack of intervillus  expression of either protein is seen in the double exposed photomicrograph  in C (the intervillus region 
is indicated by arrows). In a 14-d-old I-FABP-~77t~  transgenic mouse, the crypts are well formed and purification from polyclo- 
nality to monoclonality  has been completed.  The hGH reporter remains restricted to villus-associated  enterocytes (D-G). BrdUrd-labeled 
cells, detected with fluoresceinated secondary antibodies, clearly define the proliferative  zone in the crypt (D). I-FABP imrnunoreactivity, 
detected with Texas red-labeled secondary antibodies in E, is restricted  to villus-associated  enterocytes,  hGH immunoreactivity,  detected 
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Figure 12.  Summary of ele- 
ments in the 5' nontranscribed 
domain of rat Fabpi that regu- 
late its patterns of expression 
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and  crypt-villus  (or  crypt- 
surface epithelial cuff) axes. 
See text for discussion. 
As noted in the introduction, the differentiation programs 
of the four principal gut epithelial cell lineages are expressed 
as these descendants  of a  single,  active multipotent crypt 
stem cell undergo a spatially constrained amplification and 
bipolar migration along the crypt-villus axis.  Nucleotides 
-277 to +28 of rat Fabpi are sufficient to recapitulate the 
normal pattern of activation of mouse Fabpi in differentiating 
enterocytes as they exit the crypt and begin their upward 
journey in vertical coherent bands to the apical extrusion 
zone of villi. Removal of nucleotides -277 to -185 results 
in inappropriate expression of  hGH in proliferating epithelial 
cells located in the mid portion of intestinal crypts. Despite 
this precocious activation, accumulation of the reporter is 
subsequently restricted to differentiated enterocytes; hGH is 
not detectable in the differentiated products of the Paneth, 
goblet, or enteroendocrine cell lineages. This finding sug- 
gests several conclusions. First, many of the regulatory fac- 
tors  necessary for transcription of Fabpi have apparently 
already been synthesized and are functional within the repli- 
cating descendants of the multipotent crypt stem cell. Sec- 
ond, the inappropriate crypt expression of I-FABP  -~u ~o ,28/ 
hGH  §  is not the result of a general de-repression of trans- 
gene expression since enterocyte-specific and region-appro- 
priate patterns of reporter production are observed. Rather, 
expression of Fabpi appears to be specifically suppressed in 
crypt epithelial cells through the action of cis-acting regula- 
tory elements located between nucleotides -277 and -184. 
This finding provides the first clues about the mechanisms 
that normally modulate gene expression during transloca- 
tion/differentiation of enterocytes along the crypt-villus axis. 
The CCAAT-enhancer binding proteins have been implicated 
in (a) activation of genes that confer a specialized phenotype 
to a differentiated cell although they do not appear to be able 
to independently specify a terminal differentiation program, 
and  (b)  in  the  production  of  a  nonproliferating  state 
(reviewed in  Umek et al.,  1991).  Although C/EBPo~ foot- 
prints to nucleotides -188 to -167 of Fabpi in vitro, its role 
in regulating differentiation-dependent activation of Fabpi in 
nonproliferating members of the enterocytic lineage remains 
to  be  established.  For  example,  the  cellular  patterns  of 
C/EBPot expression have yet to be fully defined in the gut 
epithelium, nor have those of C/EBP~ and C/EBP6 which 
are also expressed in the intestine and form mixed dimers 
with one another and C/EBPot (Cao et al.,  1991). 
The third conclusion which can be made from these results 
deals with the point at which allocation to a particular gut 
cell lineage occurs during the processes of amplification and 
migration. The fact that I-FABP  -~ ~ +2S/hGH+3 expression 
occurs in replicating crypt epithelial cells yet is ultimately 
restricted to the enterocytic lineage in both small intestine 
and colon suggests that the replicating cells are already corn- 
mired to the enterocytic  lineage or that the proliferating cells 
are not fully committed and nucleotides -184 to +28 con- 
tain  cis-acting  elements  which bind  lineage specific sup- 
with IGSS, is also confined to villus enterocytes (F). Triple exposure of BrdUrd, I-FABP, arid hGH immunoreactivity in G confirms that 
I-FABP and hGH are not detectable in crypt epithelial ceils. (H-d) I-FABP  -l~* to +2S/hGH+3 directs transgene expression to nascent in- 
testinal crypts in neonatal mice. hGH immunostaining of the small intestine from both 1-d-old (H) and 7-d-old (I) transgenic animals 
shows labeling of cells in the intervillus epithelium (indicated by arrows). (J) Immunostaining of the proximal colon from a 7-d-old 
I_FABP-t~ to +2S/hGH+3 mouse reveals the reporter in the upper segments of the developing crypt-surface epithelial cuff axis. (K-N) ex- 
pression of I-FABP  -to3 to +2S/hGH+3 in a 2-wk-old mouse. A section of small intestine was incubated with antibodies against BrdUrd, 
I-FABP, and hGH. The fluorescein-labeled BrdUrd-immunoreactive cells in K define the crypt cell zone, while Texas red-labeled I-FABP 
immunoreaetive ceils in L define the villus epithelium. Relatively weak, focal hGH immunoreactivity, visualized by the IGSS method, 
is apparent in M (indicated by arrows). Multiexposure of the section in N, indicates that hGH is limited to villus-associated enterocytes. 
The staining was generally too weak to make conclusions about whether the reporter is also present in proliferating and/or nonproliferating 
crypt epithelial ceils. Bar, 25/~m. 
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allocated to  enteroendocrine, goblet  and  Paneth  cell lin- 
eages. Alternatively, suppression of hGH synthesis after al- 
location to these lineages could reflect loss of a positive fac- 
tor, produced in uncommitted cells, that binds to elements 
located between nucleotides -184 to  +28 (this loss would 
presumably occur during differentiation of enteroendocrine, 
goblet and Paneth ceils but not enterocytes). The apparent 
restriction of I-FABP  -~4 to +28/hGH expression to the entero- 
cytic lineage is interesting in light of our previous studies of 
transgenic mice that contain nucleotides -4000 to +21 or 
-596 to +21 of the homologous liver fatty acid binding pro- 
tein gene (Fabpl) linked to a variety of reporters including 
hGH (Sweetser et al., 1988b; Hansbrough et al., 1991). The 
intact, endogenous mouse Fabpl gene is normally restricted 
to the enterocytic lineage, although a very small subpopula- 
tion of enteroendocrine cells located in proximal small intes- 
tinal villi contains detectable levels of this cytoplasmic long 
chain  fatty acid binding protein (Sweetser et al.,  1988b; 
Roth et al.,  1990). Like Fabpi, Fabpl is activated as entero- 
cytes  exit  small  intestinal  crypts.  L-FABP  -4~  to  +21  and 
L_FABP-596 to  §  direct inappropriate  expression of these 
reporters in proliferating and nonproliferating small intesti- 
nal and colonic crypt epithelial cells (S weetser et al., 1988b; 
Trahair et al.,  1990; Roth and Gordon,  1990; Cohn et al., 
1991; Hansbrough et al.,  1991;  Rubin et al.,  1991,  1992; 
Roth  et al.,  1991b).  The cellular distribution  of hGH  in 
the crypts of L-FABP  -4~176176  to +2S/hGH+3 and L-FABP  -596 to § 
hGH  +3 animals is somewhat different than the cellular dis- 
tribution  observed in  comparably  aged  I-FABP  -'s4  to  +~s/ 
hGH  §  transgenic  mice:  the  L-FABP/hGH transgenes  are 
first activated in cells that are closer to the base of crypts 
where the multipotent stem cell is presumed to reside (Potten 
and Loeffler, 1990) and the steady-state level of their hGH 
product is maintained at higher levels in both proliferating 
and nonproliferating cells during their translocation through 
the crypts (Sweetser et al., 1988b and data not shown). Pre- 
cocious expression of hGH in the crypts of multiple pedi- 
grees of L-FABP  -4~~  to +2S/hGH+3  and L-FABP  -59~ to +2S/hGH+3 
mice is associated with "appropriate" production of the re- 
porter in enterocytes and inappropriate production in fully 
differentiated members of the enteroendocrine, the goblet 
cell, and the Paneth cell lineages (Roth et al., 1990; 1991a,b; 
1992b; Roth and Gordon, 1990; Trahalr et al.,  1990; Cohn 
et al.,  1991).  One possible interpretation of these results is 
that  nucleotides  -4000  to  +28  do  not contain  lineage- 
specific suppressor elements comparable with those postu- 
lated to be located between nucleotides  -184 to  +28  of 
Fabpi.  Alternatively,  these  two  L-FABP/hGH transgenes 
may be activated in crypt epithelial cells that are uncommit- 
ted, or less committed, than those cells which initially sup- 
port I-FABP  -184 to +2S/hGH+3 activation (i.e., L-FABP/hGH 
may be initially expressed in the multipotent stem cell or one 
of its immediate descendants).  Whatever the mechanisms, 
transgenes appear to be potentially useful probes for opera- 
tionally defining where and how lineage allocation occurs in 
the  crypt.  For example,  crossing  I-FABP  -~u  to +2S/hGH+3 
transgenic mice with mice that contain transgenes composed 
of L-FABP  -596 to +21 linked to a different reporter would al- 
low assessment of which  crypt epithelial cell populations 
support expression of one or both transgenes and their rela- 
tive locations along  the  basal-apical  axis.  Moreover, the 
recent development of methods for preparing primary cul- 
tures  of suckling  crypt and  villus  epithelial  cell popula- 
tions (Evans et al.,  1992), may allow mice containing both 
I_FABP-~S4  ,o  +~8/reporte  r  and  L-FABP  -596  to  +2Vreporte  r 
transgenes to be used for isolation of gut stem cells, their 
early descendants, and/or members of specific lineages if the 
reporters encode gene products that allow for positive and 
negative selection ex vivo. 
A  fourth conclusion that can be made from the experi- 
ments described here is that nucleotides -103 to +28 of rat 
Fabpi contain cis-acting elements which are sufficient to pro- 
duce appropriate developmental stage-specific activation of 
hGH expression along the cephalocaudal axis of the gut but 
lack elements necessary to sustain similar levels of expres- 
sion  beyond  the  suckling/weaning  period.  Addition  of 
nucleotides -  184 to -104 or -277 to -104 did not modify 
the proper temporal pattern of activation of reporter produc- 
tion during  E16-20 nor  did they "prevent" a  several fold 
reduction in steady state hGH mRNA levels between postna- 
tal weeks 2 and 21. Analyses of I-FABP  -~lTs to +28/hGH+3 or 
I_FABP-H7s to +2s/SV_40 T  antigen transgenic mice suggest 
that nucleotides -1178 to +28 of rat Fabpi contain cis-acting 
elements that are sufficient to sustain reporter mRNA levels 
through at least the first nine months of life (Sweetser et al., 
1988a; Hauft et al., 1992 and data not shown). It is tempting 
to  speculate  that  the  conserved  domain  I,  which  spans 
nucleotides -594 to  -420, and/or its associated 14-bp re- 
peat (Fig. 12) may function as a positive transcriptional ele- 
ment which is involved in sustaining Fabpi  expression during 
postnatal life. It appears unlikely that the postnatal fall in 
hGH mRNA and protein levels (the latter evident by immu- 
nocytochemical surveys of sections of intestine and by mea- 
surement  of serum  hGH  concentrations)  is  mediated  by 
glucocorticoids, thyroxine, or by luminal contents. Although 
marked increases in glucocorticoids and thyroxine levels oc- 
cur at the suckling/weaning transition and mediate a number 
of changes in gene expression within the enterocytic lineage 
(Malo and Menard,  1983; Henning, 1987), analysis of nor- 
mal mice and rats or mice with congenital hypothyroidism, 
produced by a recessive mutation known as hyt, indicates that 
neither precocious administration of glucocorticoids, adre- 
nalectomy,  nor  thyroid hormone  deficiency affects Fabpi 
expression (Green et al.,  1989; N. Nanthakumar and S. J. 
Henning, personal communication). Moreover, studies of in- 
testinal isografts harvested from El6 mice and implanted 
into the subcutaneous tissues of adult CBY/B6 recipients re- 
veal that Fabpi expression is sustained for up to 2 mos in 
villus-associated enterocytes distributed along the duodenal- 
colonic axis  (Rubin  et  al.,  1992).  One  obvious  question 
is what role the reporter plays in the postnatal  decreases 
in  I-FABP  -277  to  +2S/hGH+3, i_FABP-lS4 to  +2S/hGH+3 and 
I-FABP  -1~  to +2S/hGH  +3 expression, hGH production is ex- 
tinguished  in  aging  transgenic  mice  containing  L-FABP/ 
hGH fusion genes (Colin et al.,  1991).  However, the tem- 
poral and spatial pattern of silencing of L-FABP  -4~176176  to § 
hGH  +3  or  L-FABP  -596  to  +2I/hGH+3 differs  from  that  of 
I-FABP/hGH: it is restricted to the colon and occurs in a 
"wave" that progresses from the distal to proximal portions 
of the large bowel over a 6-12-m0 period. The decision to 
extinguish L-FABP/hGH expression appears to be made at 
the  level of the  crypt stem  cell or  one of its  immediate 
descendants,  and is coordinated between adjacent colonic 
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Ionic  glands  (Cohn  et al.,  1991).  In  contrast,  the  reduc- 
tion in I-FABP/hGH expression is more rapid, affects the en- 
tire cephalocaudal  axis,  and produces a diminution  in the 
steady state levels of hGH in all  villus-associated entero- 
cytes.  It  does  not  involve  the  progressive  appearance  of 
coherent,  wholly positive bands  of hGH-negative  entero- 
cytes extending from a crypt to the apex of a villus, as would 
be expected if the decision to suppress transgene expression 
were made at the level of a single crypt stem cell that supplies 
a polyclonal villus (see introduction, and Roth et al.,  1991b). 2 
Although  the  mechanism  of  postnatal  suppression  of 
I-FABP/hGH expression is currently unknown, these obser- 
vations emphasize that mice containing Fabpi/reporter  trans- 
genes represent powerful model systems for further defining 
how gene expression is regulated in specific gut epithelial 
cell lineages as a function of their "positional address" along 
the duodenal-colonic and crypt-villus axes and as a function 
of their "temporal address" in this rapidly yet continuously 
renewing system. 
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